Chronic lymphocytic leukaemia trials in Chile

3 of 3 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

  Where

  Concepción, La Serena, Santiago

  Age

  18 years and over

  People

  735 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT05947851 · EU 2022-501560-17-00
• Phase 3Taking people
  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Where

  Santiago

  Age

  18 years and over

  People

  1,200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136559 · EU 2022-501697-19-01
• Phase 3Taking people
  A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  Where

  Santiago, Temuco, Viña del Mar

  Age

  18 years and over

  People

  737 worldwide

  Run by

  Loxo Oncology, Inc.

  See details and how to joinNCT05254743 · EU 2023-507699-38-00